Mm.ig.(2023).zip

: Usage of de novo peptide sequencing, molecular docking, or total RNA sequencing (RNA-Seq) to identify malignant signatures. 3. Results and Data Analysis

Summarize how the data in the 2023 archive supports individualized risk assessment and novel therapeutic targets in oncology. MM.IG.(2023).zip

: Raw DNA or RNA sequences of immunoglobulin genes. : Usage of de novo peptide sequencing, molecular

Draft Outline: "Advancements in Multiple Myeloma and Immunoglobulin Profiling (2023)" MM.IG.(2023).zip